FDA recall, , Moderate risk
ARUP Laboratories Apheresis Platelets, Leukocytes Reduced
Apheresis Platelets, Leukocytes Reduced were distributed without pH testing.
Recall ended Jun 25, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
ARUP Laboratories, Inc. began a recall of Apheresis Platelets, Leukocytes Reduced on August 12, 2025, because the product was distributed without pH testing. The FDA added the recall to its Enforcement Report and classified it on June 25, 2026. The recall was listed in the FDA's weekly enforcement report on July 1, 2026, and involved the state of Utah.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- ARUP Laboratories, Inc.
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99053
- Recall number
- B-0105-2026
All recalls from ARUP Laboratories, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
